Could cause temporary or reversible harm; serious harm is unlikely.
Defective Container: products potentially could have been packaged in defective bottles, with a notched rim, that could cause inadequate foil sealing resulting in lack of moisture protection.
| Brand name | CADUET |
| Generic name | AMLODIPINE AND ATORVASTATIN |
| Active ingredient(s) | AMLODIPINE BESYLATE, ATORVASTATIN CALCIUM TRIHYDRATE |
| Distributed by / for | Pfizer Labs, Division of Pfizer Inc. NY, NY 10017 |
| NDC | 0069-2160-30 |
| Full product label | Caduet (amlodipine besylate/atorvastatin calcium) Tablets, 10 mg/10 mg*, 30-count bottle, Rx only, Distributed by: Pfizer Labs, Division of Pfizer Inc. NY, NY 10017, Made in Germany, NDC 0069-2160-30. |
| Recalling firm | Pfizer Inc. |
| Distribution | Nationwide in the USA. |
| Quantity | 128 bottles |
| Recall initiated | 2020-02-05 |
| Report date | 2020-02-19 |
| Recall completed | 2021-03-08 |
| Recall number | D-0842-2020 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | New York NY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗